Psilocybin Provides Long-Term Relief of Cancer-Related Anxiety, Depression: Study
A follow-up study has found long-term relief from anxiety and depression related to cancer diagnoses with use of psilocybin treatment.
psilocybin
Psilocybin’s Relationship with Creativity a ‘Complicated’ Affair, Study Finds
New research points to a connection between psilocybin mushrooms and creativity.
Psilocybin As Effective as Lexapro in Treating Depression: Study
The first study of its kind compares psilocybin and the antidepressant Lexapro in treating depression. The results are promising.
Lower Doses of Psilocybin May Still Have Antidepressant Effects
Psilocybin taken at low doses could have powerful antidepressant effects, according to new research findings.
Mydecine Prepares to Present Four Novel Psychedelic Candidates
Colorado-based Mydecine is launching four new psychedelic candidates for use in treating conditions like anxiety and depression.
Yale to Study Psilocybin for Cluster Headaches
Psilocybin is showing relief as treatment for cluster headaches — a painful condition that affects more than 300,000 Americans a year.
Psychedelic Business News Spotlight: April 2, 2021
This week in psychedelic business news: cannabis dives in, ketamine delivery, and psilocybin for autism anxiety.
Mass General to Study Psilocybin at New Psychedelic Research Center
Massachusetts General Hospital has launched a new center for psychedelic research. First up: the benefits of psilocybin.
New Research Investigates Psilocybin as OCD Treatment
Researchers are looking at how psilocybin and other psychedelics may help with OCD (obsessive-compulsive disorder).
New Study Finds Possible Mechanism for Psilocybin’s Anti-Depressive Effects
Scientists are closer to unraveling the mystery behind the psilocybin effects and its ability to offer anti-depressive benefits.
End of content
End of content